Log in to search using one of your social media accounts:

 

Epilepsy drug could help prevent TINNITUS because it reduces 'hyperactivity' of cells in the ear

Researchers from the University of Pittsburgh found that retigabine prevented the chronic and often debilitating hearing condition from developing after exposure to loud noise in mice.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Vaibhav Kumar Jain, Vivek Singh, Vikas Kannaujia, Priyadarshini Mishra, Rajendra Vishnu Phadke, Kumudini SharmaIndian Journal of Ophthalmology 2018 66(5):714-717 This case series aimed to review the significance of revisiting papilledema after successful cerebral venous sinus thrombosis (CVST) management with sinus angioplasty. Four patients presented with blurring and transient obscuration of vision with papilledema, headache, tinnitus, and vomiting. On magnetic resonance venography and digital subtraction angiography, chronic transverse sinus thrombosis was diagnosed for which patients underwent endovascular interventio...
Source: Indian Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research
Medicine made from the cannabis plant for severe seizures in children with epilepsy ‚Äč has moved one step closer to U.S. approval
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
An FDA advisory committee has voted to support approval of a formulation of cannabidiol as an adjunctive treatment for Lennox-Gastaut syndrome and Dravet syndrome in patients 2 years of age or older.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Epidiolex was developed to treat two rare and devastating forms of the disease. It contains a chemical compound found in marijuana but not the one that makes people high.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Marijuana Food and Drug Administration Epilepsy Seizures (Medical) Drugs (Pharmaceuticals) Epidiolex GW Pharmaceuticals Source Type: news
Stimulants are a preferred option for treating attention-deficit/hyperactivity disorder (ADHD), but concerns remain about their potential for misuse. A smallstudy in theJournal of Clinical Psychiatrynow suggests that treating patients with ADHD with a combination of the opioid blocker naltrexone and methylphenidate could reduce the feelings of euphoria some patients experience when taking stimulants.For the study, Thomas Spencer, M.D., the assistant chief of the Pediatric Psychopharmacology Research Program at Massachusetts General Hospital, and colleagues enrolled 37 young adults (aged 18 to 30) with ADHD who reported a f...
Source: Psychiatr News - Category: Psychiatry Tags: ADHD euphoria Journal of Clinical Psychiatry methylphenidate naltrexone stimulants Thomas Spencer Source Type: research
(MedPage Today) -- Cannabidiol medication would be first cannabis-derived drug approved in U.S.
Source: MedPage Today Public Health - Category: American Health Source Type: news
A FDA advisory committee unanimously approved an experimental drug made from marijuana to treat seizures associated rare epilepsy affecting children.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
The drug, Epidiolex, was developed by London's GW Pharmaceuticals and is a pharmaceutical-grade form of cannabidiol, or CBD, an oil found in marijuana plants. GW grows the plant in greenhouses and purifies out the CBD.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NASDAQ:GWPH Source Type: news
Conclusion: While a rare finding, interictal PET hypermetabolism does occur, may help identify epileptogenic zones, and assessment to reveal it should be made by concomitant use of surface EEG during PET scans.Pediatr Neurosurg
Source: Pediatric Neurosurgery - Category: Neurosurgery Source Type: research
(Reuters) - An advisory panel to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of approving the first cannabis-derived medicine in the country, a childhood epilepsy treatment developed by GW Pharma.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Epilepsy | Health | Hyperactivity | Tinnitus